ARCHIVES

Radio-Immunotherapy Advances May Rival Those With Drugs

This article is from The Cancer Letter archive.

Vol. 02 No. 16 | April 16, 1976

Download PDF Visit The Full Archive

Related Articles

Consructio Needs Over Next Five Years Total Estimated $696 Million; NCI Share-$132 Million

January 19, 1979

New NCI advisory Boards Appointed, Begin Review Of NCI Programs

March 29, 1996

FDA Approves Rituxan For NHL With CHOP Therapy

February 24, 2006

In Congress: NCI Apologizes For Delay In Report On Radioactive Fallout

September 18, 1998

In Brief: Richard Fisher Named Physician-in-Chief, Executive Vice President at Fox Chase Cancer Center

December 7, 2012

Enzastaurin Shows Activity In Recurrent High-Grade Glioma

June 24, 2005